Private Label: A Riddle Wrapped In A Mystery Inside An Enigma For Major Supplement Manufacturers
This article was originally published in The Tan Sheet
Executive Summary
GNC looks at restoring growth to its private label and contract manufacturing business and Vitamin Shoppe works on getting its business growing, but NBTY continues to lament the drag the segment is having on its overall growth.
You may also be interested in...
GNC, Vitamin Shoppe Not On Same Page In Solving Similar Growth Challenges
Common thread between the manufacturers and retail chain operators offering their own and other brands extends to relatively recent executive suite shakeups following extended stretches of declining sales growth. GNC reported nearly $70m net income for 2018 after two years of net losses and Vitamin Shoppe trimmed its loss by more than $200m from 2017 to $12.1m.
Executive Decisions Roundup: Vitamin Shoppe, Mead Johnson, MusclePharm
Watts heads Vitamin Shoppe; Mead Johnson CFO Leemputte leaving; MusclePharm makes branding chief, CFO changes.
NBTY Targets Unleashing Growth From Private Label Drag
“Where we have opportunities to hold on to” private label business, “we'll hold on to it, but not at any cost,” says President and CEO Steve Cahillane. “Due to private label margins” becomes common refrain in NBTY’s income downturn.